• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

AstraZeneca

Goal disorientation and lack of vision
Biotech

AstraZeneca amyloidosis drug fails to reduce mortality in ph. 3

Plans for an amyloidosis blockbuster look further out of reach after the anti-fibril antibody failed to reduce deaths and hospitalizations.
James Waldron Jul 16, 2025 4:28am
bet poker chips las vegas betting gamble

AstraZeneca’s $1.3B hypertension med bet pays off with ph. 3 win

Jul 14, 2025 4:09am
Glowing puzzle piece fitting into puzzle

Eolas regains opioid use disorder drug abandoned by AstraZeneca

Jul 10, 2025 9:33am
reshuffle pipeline target reorganize shift change

AstraZeneca’s Alexion pens $825M AAV capsid pact with JCR

Jul 9, 2025 4:52am
Horseshoe magnet attracting metallic pawn people

Biotech shares first data for in vivo CAR-T that attracted AZ

Jul 7, 2025 2:27pm
Question
Favicon Fierce Pharma

Summit in high-stakes deal talks with AstraZeneca: Bloomberg

Jul 7, 2025 10:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings